デフォルト表紙
市場調査レポート
商品コード
1224649

in vitro診断の北米市場規模、シェア、動向分析レポート:製品別(機器、試薬、サービス)、技術別、用途別、最終用途別、検査場所別、地域別、セグメント予測、2023年~2030年

North America In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Services), By Technology, By Application, By End-use, By Test Location, By Region, And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 280 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.55円
in vitro診断の北米市場規模、シェア、動向分析レポート:製品別(機器、試薬、サービス)、技術別、用途別、最終用途別、検査場所別、地域別、セグメント予測、2023年~2030年
出版日: 2023年01月25日
発行: Grand View Research
ページ情報: 英文 280 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米のin vitro診断市場の成長と動向

Grand View Research, Inc.の最新レポートによると、北米のin vitro診断市場規模は2030年までに396億7000万米ドルに達し、2023年から2030年までCAGR2.89%で減少すると予想されています。一方、同市場は、主要セグメントにおけるさまざまな成長機会に対応することも期待されています。例えば、正確で効率的、かつエラーのない診断を提供するための病院や研究所向けの自動体外診断ソリューションの開発は、今後数年間の市場成長を促進すると予想されます。また、POCソリューションの開発に対する取り組みの高まりや、感染症、妊娠、がんなど、さまざまな医療診断アプリケーションにおけるPOCテストの採用急増が、市場の成長を後押ししています。

使いやすく、高度で柔軟な検査オプションを可能にする、高速で正確な製品を開発するための主要参入企業の努力の高まりが、市場成長を後押しすると思われます。例えば、2022年8月、DxGen Corp.とPrecision Diabetes, Inc.は、糖尿病検査の完全なプロファイルを測定する全自動POC分析装置を開発し、米国市場で発売することで合意したと発表しています。この分析器は、POC施設において、CRP、尿検査、A1C値、その他の糖尿病確認検査を行うことができます。

さらに、2021年11月、POC診断の主要企業であるLumos Diagnosticsは、Lumos CoviDx SARS-CoV-2 Rapid Antigen Testがカナダ保健省から中間発注認可を取得したと発表しました。この検査は、無症候性患者の連続検査において、わずか15~20分で簡単に判定できる結果を提供します。在宅医療、地域薬局、小売診療所、緊急医療センター、集中治療室、手術室などでポイントオブケア検査が簡単に利用できることが、地域全体でのPOC IVD製品の普及に拍車をかけています。

北米のin vitro診断業界は、診断ラボが完全自動化ツールを頻繁に採用していることから、牽引力を増しています。さらに、自動化装置は拡張性が高く、期待される性能を高いレベルで満たし、バッチテストを排除し、医療従事者に迅速な結果を提供します。主要な参加企業は、これらの利点から、自動化装置の構築に継続的に取り組んでいます。例えば、2022年5月、BDは米国市場において、新しい完全自動化ハイスループット感染症分子診断プラットフォームを発売しました。

さらに、対象疾患の発生率の増加、政府の有利な取り組み、地域の盛んなヘルスケア部門は、有利な成長機会を提供すると予測されます。

例えば、2022年11月、ホロジック社はBARDAから研究開発活動を支援するための1900万米ドルの契約を獲得しました。また、2022年1月には、Aline, Inc.とNectar Product Developmentが、POCin vitro診断を改善するための戦略的パートナーシップを発表しています。

北米のin vitro診断市場レポートハイライト

試薬部門が2022年に最大の市場シェアを占めたのは、新規検査キットの開発のために主要な市場プレーヤーが行っている大規模な研究開発イニシアチブのためである

分子診断セグメントは、技術の急速な進化、対象疾患の負担増、主要参入企業による製品上市の急増により、2022年に最大の市場シェアを占めた

アプリケーション別では、感染症分野が2022年の収益シェアで市場を独占。一方、予測期間中は、腫瘍セグメントが最も急速に成長すると予想される

手頃な価格のサービスに対する需要の高まり、個別化された治療に対する傾向の急増、有利な償還政策の存在などにより、2022年のエンドユーザーとしては病院セグメントが最大となった

高齢者人口の増加、慢性疾患の有病率が高い大規模な患者プールにより、カナダが予測期間中に最も速い成長を示すと予想される

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
  • 調査手法
  • 情報調達
    • 購入したデータベース:
    • Gvrの内部データベース
    • 二次情報
    • 1次調査
  • 情報またはデータ分析
    • データ分析モデル
  • 市場の策定と検証
  • モデルの詳細
    • コモディティフロー分析(モデル1)
      • アプローチ1:コモディティフローアプローチ
  • 調査の仮定
  • 二次情報のリスト
  • 略語一覧
  • 目的

第2章 エグゼクティブサマリー

  • 市場のスナップショット
  • セグメントのスナップショット
  • 競合情勢のスナップショット

第3章 北米のin vitro診断市場の変数、動向、および範囲

  • in vitro診断市場系統の見通し
    • 親市場の見通し
  • 浸透と成長の見通しのマッピング
  • 市場促進要因分析
    • 高齢者人口の増加
    • 技術の進歩
    • Poc施設の需要の増加
    • 遺伝性疾患、心血管疾患、神経疾患、院内感染などの標的疾患の蔓延
    • COVID-19の発生
  • 市場抑制要因分析
    • デバイスの高コスト
    • 厳格な規制ポリシー
  • SWOT分析、要因別(政治と法律、経済、技術)
  • ポーターのファイブフォース分析
  • フェーズ別のパイプライン分析
  • 規制と償還のシナリオ
  • 価格分析

第4章 北米のin vitro診断市場セグメント分析、製品別、2018年から2030年(ボリューム、テストおよび機器の数、収益、USD Million、2018年から2030年)

  • 北米の体外診断市場:製品変動分析
  • 機器
    • 病院
    • 研究所
    • ホームケア
    • クリニック
      • 診療所
      • 薬局と小売クリニック
      • 非診療所
      • 緊急治療クリニック
      • その他
  • 試薬
    • 病院
    • 研究所
    • ホームケア
    • クリニック
      • 診療所
      • 薬局と小売クリニック
      • 非診療所
      • 緊急治療クリニック
      • その他
  • サービス
    • 病院
    • 研究所
    • ホームケア
    • クリニック
      • 診療所
      • 薬局と小売クリニック
      • 非診療所
      • 緊急治療クリニック
      • その他

第5章 北米のin vitro診断市場セグメント分析、テクノロジー別、2018年から2030年(収益、百万米ドル)(ボリューム、テストおよび機器の数)

  • 北米の体外診断市場:技術変動分析
  • イムノアッセイ
    • 製品
      • 機器
      • 試薬
      • サービス
    • 最終用途
      • 病院
      • 研究所
      • ホームケア
      • クリニック
      • 診療所
      • 薬局と小売クリニック
      • 非診療所
      • 緊急治療クリニック
      • その他
  • 血液学
    • 製品
      • 機器
      • 試薬
      • サービス
    • 最終用途
      • 病院
      • 研究所
      • ホームケア
      • クリニック
      • 診療所
      • 薬局と小売クリニック
      • 非診療所
      • 緊急治療クリニック
      • その他
  • 臨床化学
    • 製品
      • 機器
      • 試薬
      • サービス
    • 最終用途
      • 病院
      • 研究所
      • ホームケア
      • クリニック
      • 診療所
      • 薬局と小売クリニック
      • 非診療所
      • 緊急治療クリニック
      • その他
  • 分子診断学
    • 製品
      • 機器
      • 試薬
      • サービス
    • 最終用途
      • 病院
      • 研究所
      • ホームケア
      • クリニック
      • 診療所
      • 薬局と小売クリニック
      • 非診療所
      • 緊急治療クリニック
      • その他
  • 凝固
    • 製品
      • 機器
      • 試薬
      • サービス
    • 最終用途
      • 病院
      • 研究所
      • ホームケア
      • クリニック
      • 診療所
      • 薬局と小売クリニック
      • 非診療所
      • 緊急治療クリニック
      • その他
  • 微生物学
    • 製品
      • 機器
      • 試薬
      • サービス
    • 最終用途
      • 病院
      • 研究所
      • ホームケア
      • クリニック
      • 診療所
      • 薬局と小売クリニック
      • 非診療所
      • 緊急治療クリニック
      • その他
  • その他
    • 機器
    • 試薬
    • サービス

第6章 北米のin vitro診断市場:セグメント分析、アプリケーション別、2018年から2030年(100万米ドル)

  • 北米の体外診断市場:アプリケーションの変動分析
  • 感染症
    • 疾患
      • メチシリン耐性黄色ブドウ球菌(Mrsa)
      • クロストリジウム・ディフィシル
      • バンコマイシン耐性腸球菌(Vre)
      • カルバペネム耐性菌
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Leading Market Players Anticipated to Witness Highest Growth
  • Table 4 North America In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 5 North America In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 6 North America In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 7 North America In Vitro Diagnostics Market, By Route of Application, 2018 - 2030 (USD Million)
  • Table 8 North America In Vitro Diagnostics Market, By End-Use, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 9 North America In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million)
  • Table 10 U.S. In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 11 U.S. In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 12 U.S. In Vitro Diagnostics Market, By Route of Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. In Vitro Diagnostics Market, By End-Use, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 14 U.S. In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million)
  • Table 15 Canada In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 16 Canada In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 17 Canada In Vitro Diagnostics Market, By Route of Application, 2018 - 2030 (USD Million)
  • Table 18 Canada In Vitro Diagnostics Market, By End-Use, 2018 - 2030 (USD Million) (Number of
  • Table 19 Canada In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 North America in vitro diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Segment snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Penetration and growth prospect mapping
  • Fig. 15 North America in vitro diagnostic market driver impact
  • Fig. 16 Geriatric population in the U.S.
  • Fig. 17 Comparison of geriatric population in the U.S.
  • Fig. 18 Proportion of Canadian population in 2022
  • Fig. 19 Number of deaths for leading causes of death
  • Fig. 20 North America in vitro diagnostics market restraint impact
  • Fig. 21 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 22 Porter's five forces analysis
  • Fig. 23 Taking control of the changing regulatory landscape
  • Fig. 24 North America IVD market: Product outlook and key takeaways
  • Fig. 25 North America. IVD market: Products movement analysis
  • Fig. 26 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Home care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Clinic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Physician office market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Pharmacy & retail clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Non-practice clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Urgent care clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Home care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Clinic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Physician office market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Pharmacy & retail clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Non-practice clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Urgent care clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Home care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Clinic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Physician office market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Pharmacy & retail clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Non-practice clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Urgent care clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 North America IVD market: Technology outlook and key takeaways
  • Fig. 57 North America IVD market: Technology movement analysis
  • Fig. 58 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Instruments market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Reagents market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Services market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Instruments market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Pharmacy & retail clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Services market for other technology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 North America IVD market: Application outlook and key takeaways
  • Fig. 68 North America IVD market: Application movement analysis
  • Fig. 69 Meningitis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Percentage of osteoporosis affecting men and women
  • Fig. 71 North America IVD market: End-use outlook and key takeaways
  • Fig. 72 Home care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Key stats related to retail clinics in the U.S.
  • Fig. 74 Regional marketplace: Key takeaways
  • Fig. 75 North America: SWOT analysis
  • Fig. 76 North America IVD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Risk factors and major chronic diseases in the U.S.
  • Fig. 79 U.S. healthcare reimbursement and financing structure
  • Fig. 80 U.S. IVD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Target disease prevalence in Canada
  • Fig. 83 Canada IVD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Market participant categorization
  • Fig. 85 North America IVD market share analysis, 2022
  • Fig. 86 Strategic framework
  • Fig. 87 Competition categorization
  • Fig. 88 Company market position analysis
  • Fig. 89 Company market position analysis
  • Fig. 90 Company market position analysis
  • Fig. 91 Regional network map
目次
Product Code: GVR-4-68040-028-3

North America In Vitro Diagnostics Market Growth & Trends:

The North America in vitro diagnostics market size is expected to reach USD 39.67 billion by 2030 and is expected to decline at 2.89% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. On the other hand, the market is also expected to cater to various growth opportunities in key segments. For example, the development of automated in vitro diagnostic solutions for hospitals and laboratories to provide accurate, efficient, and error-free diagnosis is anticipated to drive market growth in the coming years. In addition, rising efforts to develop POC solutions and the surge in adoption of POC tests across different medical diagnostic applications, including infectious diseases, pregnancy, cancer, and others, are fueling the market growth.

The market growth is likely to be fueled by rising efforts from leading participants to develop fast and accurate products that allow easy-to-use, advanced, and flexible testing options. For instance, in August 2022, DxGen Corp. and Precision Diabetes, Inc. announced an agreement to develop and launch a fully automatic POC analyzer in the U.S. market to measure a complete profile of diabetes tests. The analyzer is capable to test C-reactive protein, urine analysis, A1C levels, and other diabetes confirmatory tests at POC facilities.

Furthermore, in November 2021, Lumos Diagnostics, a key player in POC diagnostics, announced that its Lumos CoviDx SARS-CoV-2 Rapid Antigen Test received an interim order authorization from Health Canada. This test offers easy-to-interpret outcomes in just 15-20 minutes in serial testing of asymptomatic patients. The easy availability of point-of-care tests in home care settings, community pharmacies, retail health clinics, urgent care centers, intensive care units, and operating rooms is fueling the adoption of POC IVD products across the region.

The North America in vitro diagnostics industry is gaining traction as diagnostic laboratories frequently employ fully automated tools. Moreover, automated devices are highly scalable, meet a high level of performance expectations, eliminate batch testing, and provide quick results to medical professionals. Leading participants are continuously working on building automated devices because of these benefits. For instance, in May 2022, BD launched a new, fully automated high-throughput infectious disease molecular diagnostics platform in the U.S. market.

Furthermore, the increasing incidence of target diseases, favorable government initiatives, and the flourishing healthcare sector in the region are anticipated to offer lucrative growth opportunities.

For instance, in November 2022, Hologic, Inc. was awarded a USD 19 million contract from BARDA to support its research and development activities. In addition, in January 2022, Aline, Inc. & Nectar Product Development announced a strategic partnership to improve POC in vitro diagnostic products.

North America In Vitro Diagnostics Market Report Highlights:

  • The reagents segment held the largest market share in 2022 owing to extensive R&D initiatives being undertaken by major market players for the development of novel test kits
  • The molecular diagnostics segment accounted for the largest market share in 2022, thanks to rapid evolution in technology, increasing burden of target diseases, and surge in product launches by leading participants
  • Based on application, the infectious disease segment dominated the market in terms of revenue share in 2022. On the other hand, the oncology segment is expected to be the fastest-growing segment over the forecast period
  • The hospitals segment was the largest end-user in 2022, owing to the rising demand for affordable services, the surging trend for personalized treatments, and the presence of favorable reimbursement policies
  • Canada is expected to exhibit the fastest growth over the forecast period in the region due to the increasing geriatric population, and large patient pool with a high prevalence of chronic diseases

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List Of Secondary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 North America Ivd Market Variables, Trends, & Scope

  • 3.1 Ivd Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
  • 3.2 Penetration And Growth Prospect Mapping
  • 3.3 Market Driver Analysis
    • 3.3.1 Growing Geriatric Population
    • 3.3.2 Technological Advancements
    • 3.3.3 Increasing Demand For Poc Facilities
    • 3.3.4 Growing Prevalence Of Target Diseases Such As Genetic, Cardiovascular, & Neurological Diseases And Hospital-Acquired Infections
    • 3.3.5 Outbreak Of Covid-19
  • 3.4 Market Restraint Analysis
    • 3.4.1 High Cost Of Devices
    • 3.4.2 Stringent Regulatory Policies
  • 3.5 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
  • 3.6 Porter's Five Forces Analysis
  • 3.7 Pipeline Analysis, By Phase
  • 3.8 Regulatory & Reimbursement Scenario
  • 3.9 Pricing Analysis

Chapter 4 North America Ivd Market-Segment Analysis, By Product, 2018 - 2030 (Volume, Number Of Tests And Instruments; Revenue, USD Million, 2018 - 2030)

  • 4.1 North America In Vitro Diagnostic Market: Products Movement Analysis
  • 4.2 Instruments
    • 4.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.2 Hospitals
      • 4.2.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.3 Laboratories
      • 4.2.3.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.4 Home Care
      • 4.2.4.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.5 Clinic
      • 4.2.5.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.5.2 Physician Office
      • 4.2.5.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.5.3 Pharmacy & Retail Clinics
      • 4.2.5.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.5.4 Non-Practice Clinics
      • 4.2.5.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.5.5 Urgent Care Clinics
      • 4.2.5.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.5.6 Others
      • 4.2.5.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.3 Reagents
    • 4.3.1 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.3.2 Hospitals
      • 4.3.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.3.3 Laboratories
      • 4.3.3.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.3.4 Home Care
      • 4.3.4.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.3.5 Clinic
      • 4.3.5.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.3.5.2 Physician Office
      • 4.3.5.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.3.5.3 Pharmacy & Retail Clinics
      • 4.3.5.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.3.5.4 Non-Practice Clinics
      • 4.3.5.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.3.5.5 Urgent Care Clinics
      • 4.3.5.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.3.5.6 Others
      • 4.3.5.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.4 Services
    • 4.4.1 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.4.2 Hospitals
      • 4.4.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.4.3 Laboratories
      • 4.4.3.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.4.4 Home Care
      • 4.4.4.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.4.5 Clinic
      • 4.4.5.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.4.5.2 Physician Office
      • 4.4.5.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.4.5.3 Pharmacy & Retail Clinics
      • 4.4.5.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.4.5.4 Non-Practice Clinics
      • 4.4.5.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.4.5.5 Urgent Care Clinics
      • 4.4.5.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.4.5.6 Others
      • 4.4.5.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5 North America Ivd Market-Segment Analysis, By Technology, 2018 - 2030 (Revenue, USD Million) (Volume, Number Of Test And Instruments)

  • 5.1 North America In Vitro Diagnostics Market: Technology Movement Analysis
  • 5.2 Immunoassay
    • 5.2.1 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.2 Products
      • 5.2.2.1 Instruments
      • 5.2.2.1.1 Instruments Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.2.2 Reagents
      • 5.2.2.2.1 Reagents Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.2.3 Services
      • 5.2.2.3.1 Services Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.3 End-Use
      • 5.2.3.1 Hospitals
      • 5.2.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.2 Laboratories
      • 5.2.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.3 Home Care
      • 5.2.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.4 Clinic
      • 5.2.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.4.2 Physician Office
      • 5.2.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.4.3 Pharmacy & Retail Clinics
      • 5.2.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.4.4 Non-Practice Clinics
      • 5.2.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.4.5 Urgent Care Clinics
      • 5.2.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.4.6 Others
      • 5.2.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3 Hematology
    • 5.3.1 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.3.2 Products
      • 5.3.2.1 Instruments
      • 5.3.2.1.1 Instruments Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.2.2 Reagents
      • 5.3.2.2.1 Reagents Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.2.3 Services
      • 5.3.2.3.1 Services Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.3.3 End-Use
      • 5.3.3.1 Hospitals
      • 5.3.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.2 Laboratories
      • 5.3.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.3 Home Care
      • 5.3.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.4 Clinic
      • 5.3.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.4.2 Physician Office
      • 5.3.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.4.3 Pharmacy & Retail Clinics
      • 5.3.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.4.4 Non-Practice Clinics
      • 5.3.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.4.5 Urgent Care Clinics
      • 5.3.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.4.6 Others
      • 5.3.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4 Clinical Chemistry
    • 5.4.1 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.4.2 Products
      • 5.4.2.1 Instruments
      • 5.4.2.1.1 Instruments Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.2.2 Reagents
      • 5.4.2.2.1 Reagents Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.2.3 Services
      • 5.4.2.3.1 Services Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.4.3 End-Use
      • 5.4.3.1 Hospitals
      • 5.4.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.2 Laboratories
      • 5.4.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.3 Home Care
      • 5.4.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.4 Clinic
      • 5.4.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.4.2 Physician Office
      • 5.4.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.4.3 Pharmacy & Retail Clinics
      • 5.4.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.4.4 Non-Practice Clinics
      • 5.4.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.4.5 Urgent Care Clinics
      • 5.4.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.4.6 Others
      • 5.4.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.5 Molecular Diagnostics
    • 5.5.1 Molecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.5.2 Products
      • 5.5.2.1 Instruments
      • 5.5.2.1.1 Instruments Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.2.2 Reagents
      • 5.5.2.2.1 Reagents Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.2.3 Services
      • 5.5.2.3.1 Services Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.5.3 End-Use
      • 5.5.3.1 Hospitals
      • 5.5.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.2 Laboratories
      • 5.5.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.3 Home Care
      • 5.5.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.4 Clinic
      • 5.5.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.4.2 Physician Office
      • 5.5.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.4.3 Pharmacy & Retail Clinics
      • 5.5.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.4.4 Non-Practice Clinics
      • 5.5.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.4.5 Urgent Care Clinics
      • 5.5.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.4.6 Others
      • 5.5.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.6 Coagulation
    • 5.6.1 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.6.2 Products
      • 5.6.2.1 Instruments
      • 5.6.2.1.1 Instruments Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.2.2 Reagents
      • 5.6.2.2.1 Reagents Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.2.3 Services
      • 5.6.2.3.1 Services Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.6.3 End-Use
      • 5.6.3.1 Hospitals
      • 5.6.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.2 Laboratories
      • 5.6.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.3 Home Care
      • 5.6.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.4 Clinic
      • 5.6.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.4.2 Physician Office
      • 5.6.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.4.3 Pharmacy & Retail Clinics
      • 5.6.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.4.4 Non-Practice Clinics
      • 5.6.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.4.5 Urgent Care Clinics
      • 5.6.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.4.6 Others
      • 5.6.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.7 Microbiology
    • 5.7.1 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.7.2 Products
      • 5.7.2.1 Instruments
      • 5.7.2.1.1 Instruments Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.2.2 Reagents
      • 5.7.2.2.1 Reagents Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.2.3 Services
      • 5.7.2.3.1 Services Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.7.3 End-Use
      • 5.7.3.1 Hospitals
      • 5.7.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.2 Laboratories
      • 5.7.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.3 Home Care
      • 5.7.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.4 Clinic
      • 5.7.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.4.2 Physician Office
      • 5.7.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.4.3 Pharmacy & Retail Clinics
      • 5.7.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.4.4 Non-Practice Clinics
      • 5.7.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.4.5 Urgent Care Clinics
      • 5.7.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.4.6 Others
      • 5.7.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.8 Others
    • 5.8.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.8.2 Instruments
      • 5.8.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.8.3 Reagents
      • 5.8.3.1 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.8.4 Services
      • 5.8.4.1 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 North America Ivd Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 6.1 North America In Vitro Diagnostics Market: Application Movement Analysis
  • 6.2 Infectious Diseases
    • 6.2.1 Infectious Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2 Disease
      • 6.2.2.1. Methicillin-Resistant Staphylococcus Aureus (Mrsa)
      • 6.2.2.1.1 Methicillin-Resistant Staphylococcus Aureus (Mrsa) Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.1.2 Clostridium Difficile
      • 6.2.2.1.2.1 Clostridium Difficile Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.1.3 Vancomycin-Resistant Enterococci (Vre)
      • 6.2.2.1.3.1 Vancomycin-Resistant Enterococci (Vre) Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.1.4 Carbapenem-Resistant Bacteria
      • 6.2.2.1.4.1 Carbapenem-Resistant Bacteria Market Estimates And Forecast, 2018 - 2030 (USD Million)